Kistler-Tiffany Companies’s Tandem Diabetes Care TNDM Stock Holding History

Kistler-Tiffany Companies’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.07K	Hold	125	–	–	﹤0.01%	789
2023 Q1	$5.08K	Sell	125 -120	-49%	-$4.97K	﹤0.01%	688
2022 Q4	$11K	Hold	245	–	–	﹤0.01%	615
2022 Q3	$12K	Hold	245	–	–	﹤0.01%	579
2022 Q2	$15K	Hold	245	–	–	﹤0.01%	540
2022 Q1	$28K	Hold	245	–	–	0.01%	467
2021 Q4	$37K	Hold	245	–	–	0.01%	411
2021 Q3	$29K	Hold	245	–	–	0.01%	441
2021 Q2	$24K	Sell	245 -35	-13%	-$3.12K	0.01%	466
2021 Q1	$25K	Hold	280	–	–	0.01%	427
2020 Q4	$27K	Hold	280	–	–	0.01%	381
2020 Q3	$32K	Hold	280	–	–	0.01%	333
2020 Q2	$28K	Hold	280	–	–	0.01%	322
2020 Q1	$17K	Hold	280	–	–	0.01%	382
2019 Q4	$17K	Hold	280	–	–	0.01%	389
2019 Q3	$17K	Hold	280	–	–	0.01%	391
2019 Q2	$18K	Buy	280 +160	+133%	+$10.3K	0.01%	372
2019 Q1	$8K	Buy	+120	New	+$6.3K	﹤0.01%	467

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Kistler-Tiffany Companies's TNDM Position: Q2 2023 in Review

Kistler-Tiffany Companies held its Tandem Diabetes Care (TNDM) position steady in Q2 2023 at 125 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Kistler-Tiffany Companies first reported a position in TNDM in Q1 2019 and has held it in 18 quarters since. The position peaked at $37K in Q4 2021. 247 funds tracked by Wall St. Rank hold TNDM as of Q2 2023.

Kistler-Tiffany Companies held 125 shares of Tandem Diabetes Care worth $3.07K as of Q2 2023.
Kistler-Tiffany Companies left its Tandem Diabetes Care share count unchanged in Q2 2023.
Tandem Diabetes Care made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #789 holding.
Kistler-Tiffany Companies first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 18 quarters since.
Kistler-Tiffany Companies's Tandem Diabetes Care position peaked at $37K in Q4 2021.
247 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.